Andra AP-fonden’s Ionis Pharmaceuticals IONS Stock Holding History

Andra AP-fonden’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-59,700	Closed	-$2.68M	–	609
2021 Q1	$2.68M	Sell	59,700 -25,600	-30%	-$1.43M	0.06%	524
2020 Q4	$4.82M	Buy	85,300 +25,000	+41%	+$1.25M	0.11%	453
2020 Q3	$2.86M	Sell	60,300 -18,700	-24%	-$1.04M	0.08%	530
2020 Q2	$4.66M	Sell	79,000 -19,000	-19%	-$1.06M	0.14%	398
2020 Q1	$4.63M	Buy	98,000 +38,400	+64%	+$2.14M	0.17%	243
2019 Q4	$3.6M	Buy	59,600 +22,900	+62%	+$1.36M	0.1%	516
2019 Q3	$2.2M	Hold	36,700	–	–	0.07%	591
2019 Q2	$2.36M	Buy	+36,700	New	+$2.59M	0.07%	598
2016 Q3	–	Sell	-33,700	Closed	-$785K	–	620
2016 Q2	$785K	Buy	33,700 +27,000	+403%	+$871K	0.02%	633
2016 Q1	$271K	Buy	+6,700	New	+$272K	0.01%	660

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Andra AP-fonden's IONS Position: Q2 2021 in Review

Andra AP-fonden sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 59,700 shares — an estimated $2.68M sold.

Andra AP-fonden first reported a position in IONS in Q1 2016 and held it in 10 quarters. The position peaked at $4.82M in Q4 2020. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Andra AP-fonden reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Andra AP-fonden sold 59,700 Ionis Pharmaceuticals shares in Q2 2021, an estimated $2.68M.
Andra AP-fonden first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 10 quarters.
Andra AP-fonden's Ionis Pharmaceuticals position peaked at $4.82M in Q4 2020.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Andra AP-fonden's 13F filing for Q2 2021, filed 16 Aug 2021.